Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
5 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
146.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR PASCALINE SPAETH
21 RUE VILLEBOIS MAREUIL, 54000 NANCY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
American journal of hematology · 2001
AbstractThe underlying mechanisms of reactive macrophage activation syndromes (rMAS) are not understood in detail, and there is no specific treatment. This observational study was prompted by intravenous immunoglobulin (IVIG), dramatically halting two distinct rMAS episodes in the same patient. We evaluated the potential benefits of IVIG administration in treating fulminant rMAS and the usefulness of monitoring serum ferritin levels as an indication for emergency treatment with IVIG. Ten females and 10 males experiencing 22 episodes of rMAS were recruited on the basis of serum ferritin levels ≥10,000 μg/l and/or direct evidence of haemophagocytosis in 11 intensive care units in secondary and tertiary care hospitals in Switzerland between October 1993 and May 2000. In individual patients, serially measured ferritin was closely related to disease activity. Abrupt increases of up to >100,000 μg/l could be observed within hours. Rapid and profound beneficial effects of emergency IVIG treatment were seen in 12 episodes of rMAS accompanied by a prompt decrease of serum ferritin. IVIG produced partial or delayed improvements in 5 patients. No apparent effects were seen in 5 patients. IVIG was only successful if started early during the ferritin run‐up to peak values. In conclusion, IVIG is effective in at least a subgroup of adult rMAS when started at the beginning of the macrophage activation process. The monitoring of serum ferritin levels might be helpful in detecting macrophage activation in order to commence IVIG treatment early enough. Am. J. Hematol. 68:4–10, 2001. © 2001 Wiley‐Liss, Inc.
Clinical and experimental rheumatology · 1989
The Journal of rheumatology · 1991
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Wiener klinische Wochenschrift · 1993 · English Abstract
Ploier R, Tappeiner G, Spaeth P, Emhofer J
The Journal of rheumatology · 1991 · Journal Article
Corvetta A, Pomponio G, Bencivenga R, Luchetti MM, et al.
Clinical and experimental rheumatology · 1989 · Case Reports
Corvetta A, Della Bitta R, Gabrielli A, Spaeth PJ, et al.
Zeitschrift fur Rheumatologie · 1983 · Case Reports
Albert J, Spaeth PJ, Ott H, Buetler R
American journal of hematology · 2001 · Journal Article
Emmenegger U, Frey U, Reimers A, Fux C, et al.